Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development

Abstract Background The recent outbreak by SARS-CoV-2 has generated a chaos in global health and economy and claimed/infected a large number of lives. Closely resembling with SARS CoV, the present strain has manifested exceptionally higher degree of spreadability, virulence and stability possibly du...

Full description

Bibliographic Details
Main Authors: Amrita Banerjee, Dipannita Santra, Smarajit Maiti
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12967-020-02435-4
id doaj-0a12cc4d30b44924be5c28acd2c7e0f5
record_format Article
spelling doaj-0a12cc4d30b44924be5c28acd2c7e0f52020-11-25T03:52:13ZengBMCJournal of Translational Medicine1479-58762020-07-0118111410.1186/s12967-020-02435-4Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine developmentAmrita Banerjee0Dipannita Santra1Smarajit Maiti2Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and TechnologyDepartmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and TechnologyDepartmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and TechnologyAbstract Background The recent outbreak by SARS-CoV-2 has generated a chaos in global health and economy and claimed/infected a large number of lives. Closely resembling with SARS CoV, the present strain has manifested exceptionally higher degree of spreadability, virulence and stability possibly due to some unidentified mutations. The viral spike glycoprotein is very likely to interact with host Angiotensin-Converting Enzyme 2 (ACE2) and transmits its genetic materials and hijacks host machinery with extreme fidelity for self propagation. Few attempts have been made to develop a suitable vaccine or ACE2 blocker or virus-receptor inhibitor within this short period of time. Methods Here, attempt was taken to develop some therapeutic and vaccination strategies with a comparison of spike glycoproteins among SARS-CoV, MERS-CoV and the SARS-CoV-2. We verified their structure quality (SWISS-MODEL, Phyre2, and Pymol) topology (ProFunc), motifs (MEME Suite, GLAM2Scan), gene ontology based conserved domain (InterPro database) and screened several epitopes (SVMTrip) of SARS CoV-2 based on their energetics, IC50 and antigenicity with regard to their possible glycosylation and MHC/paratope binding (Vaxigen v2.0, HawkDock, ZDOCK Server) effects. Results We screened here few pairs of spike protein epitopic regions and selected their energetic, Inhibitory Concentration50 (IC50), MHC II reactivity and found some of those to be very good target for vaccination. A possible role of glycosylation on epitopic region showed profound effects on epitopic recognition. Conclusion The present work might be helpful for the urgent development of a suitable vaccination regimen against SARS CoV-2.http://link.springer.com/article/10.1186/s12967-020-02435-4SARS CoV-2 (COVID 19)Severe global outbreak-Dec 2019Spike glycoproteinACE-2 receptor proteinEpitope designing and screeningVaccination
collection DOAJ
language English
format Article
sources DOAJ
author Amrita Banerjee
Dipannita Santra
Smarajit Maiti
spellingShingle Amrita Banerjee
Dipannita Santra
Smarajit Maiti
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
Journal of Translational Medicine
SARS CoV-2 (COVID 19)
Severe global outbreak-Dec 2019
Spike glycoprotein
ACE-2 receptor protein
Epitope designing and screening
Vaccination
author_facet Amrita Banerjee
Dipannita Santra
Smarajit Maiti
author_sort Amrita Banerjee
title Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
title_short Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
title_full Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
title_fullStr Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
title_full_unstemmed Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
title_sort energetics and ic50 based epitope screening in sars cov-2 (covid 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2020-07-01
description Abstract Background The recent outbreak by SARS-CoV-2 has generated a chaos in global health and economy and claimed/infected a large number of lives. Closely resembling with SARS CoV, the present strain has manifested exceptionally higher degree of spreadability, virulence and stability possibly due to some unidentified mutations. The viral spike glycoprotein is very likely to interact with host Angiotensin-Converting Enzyme 2 (ACE2) and transmits its genetic materials and hijacks host machinery with extreme fidelity for self propagation. Few attempts have been made to develop a suitable vaccine or ACE2 blocker or virus-receptor inhibitor within this short period of time. Methods Here, attempt was taken to develop some therapeutic and vaccination strategies with a comparison of spike glycoproteins among SARS-CoV, MERS-CoV and the SARS-CoV-2. We verified their structure quality (SWISS-MODEL, Phyre2, and Pymol) topology (ProFunc), motifs (MEME Suite, GLAM2Scan), gene ontology based conserved domain (InterPro database) and screened several epitopes (SVMTrip) of SARS CoV-2 based on their energetics, IC50 and antigenicity with regard to their possible glycosylation and MHC/paratope binding (Vaxigen v2.0, HawkDock, ZDOCK Server) effects. Results We screened here few pairs of spike protein epitopic regions and selected their energetic, Inhibitory Concentration50 (IC50), MHC II reactivity and found some of those to be very good target for vaccination. A possible role of glycosylation on epitopic region showed profound effects on epitopic recognition. Conclusion The present work might be helpful for the urgent development of a suitable vaccination regimen against SARS CoV-2.
topic SARS CoV-2 (COVID 19)
Severe global outbreak-Dec 2019
Spike glycoprotein
ACE-2 receptor protein
Epitope designing and screening
Vaccination
url http://link.springer.com/article/10.1186/s12967-020-02435-4
work_keys_str_mv AT amritabanerjee energeticsandic50basedepitopescreeninginsarscov2covid19spikeproteinbyimmunoinformaticanalysisimplicatingforasuitablevaccinedevelopment
AT dipannitasantra energeticsandic50basedepitopescreeninginsarscov2covid19spikeproteinbyimmunoinformaticanalysisimplicatingforasuitablevaccinedevelopment
AT smarajitmaiti energeticsandic50basedepitopescreeninginsarscov2covid19spikeproteinbyimmunoinformaticanalysisimplicatingforasuitablevaccinedevelopment
_version_ 1724483688376303616